Patents Assigned to TETRANOV PHARMACEUTICAL CO., LTD.
  • [1,3]thiazin-2-amine compound, application, and pharmaceutical composition
    Patent number: 10889595
    Abstract: The present invention is directed to a [1,3]thiazin-2-amine compound, an application and a pharmaceutical composition, belongs to the field of BACE inhibitors. The [1,3]thiazin-2-amine compound is a compound represented by formula (I) or a pharmaceutically acceptable salt, stereoisomer, solvate or prodrug thereof. The compound has a good inhibitory effect on BACE and can be used in preparing a medicament for treating a neurodegenerative disease, such as Alzheimer's disease.
    Type: Grant
    Filed: December 14, 2017
    Date of Patent: January 12, 2021
    Assignee: TETRANOV PHARMACEUTICAL CO., LTD.
    Inventors: Yusheng Wu, Apeng Liang, Chengshan Niu, Yang Geng, Jingya Li
  • A [1,3]THIAZIN-2-AMINE COMPOUND, APPLICATION, AND PHARMACEUTICAL COMPOSITION
    Publication number: 20190330236
    Abstract: The present invention is directed to a [1,3]thiazin-2-amine compound, an application and a pharmaceutical composition, belongs to the field of BACE inhibitors. The [1,3]thiazin-2-amine compound is a compound represented by formula (I) or a pharmaceutically acceptable salt, stereoisomer, solvate or prodrug thereof. The compound has a good inhibitory effect on BACE and can be used in preparing a medicament for treating a neurodegenerative disease, such as Alzheimer's disease.
    Type: Application
    Filed: December 14, 2017
    Publication date: October 31, 2019
    Applicant: TETRANOV PHARMACEUTICAL CO., LTD.
    Inventors: Yusheng WU, Apeng LIANG, Chengshan NIU, Yang GENG, Jingya LI